Follicular Lymphoma — Where We Are, Where We're Headed in the Use of Bispecific Antibodies
Episode S26 · Ep 378 57 min 54s

Follicular Lymphoma — Where We Are, Where We're Headed in the Use of Bispecific Antibodies

Featuring perspectives from Prof Chan Chea and Dr Matthew Matasar, including the following topics:

  • Introduction (0:00)
  • Prologue: Saturday Night Fever (1:35)
  • Baby Boomers' Guide to Mechanisms of Action (3:07)
  • Second-Line Treatment (12:36)
  • Complications Associated with Bispecific Antibodies (23:41)
  • Case Presentations (25:52)
  • New Bispecific T-Cell Engagers — Surovatamig (26:24)
  • Other Novel Agents (50:05)

CME information and select publications

Community discussion